| NSAIDs inhibit tumorigenesis, but how? E Gurpinar, WE Grizzle, GA Piazza Clinical cancer research 20 (5), 1104-1113, 2014 | 225 | 2014 |
| COX-independent mechanisms of cancer chemoprevention by anti-inflammatory drugs E Gurpinar, WE Grizzle, GA Piazza Frontiers in oncology 3, 181, 2013 | 145 | 2013 |
| Sulindac selectively inhibits colon tumor cell growth by activating the cGMP/PKG pathway to suppress Wnt/β-catenin signaling N Li, Y Xi, HN Tinsley, E Gurpinar, BD Gary, B Zhu, Y Li, X Chen, ... Molecular cancer therapeutics 12 (9), 1848-1859, 2013 | 132 | 2013 |
| Phosphodiesterase 10A: a novel target for selective inhibition of colon tumor cell growth and β-catenin-dependent TCF transcriptional activity N Li, K Lee, Y Xi, B Zhu, BD Gary, V Ramírez-Alcántara, E Gurpinar, ... Oncogene 34 (12), 1499-1509, 2015 | 74 | 2015 |
| A novel sulindac derivative inhibits lung adenocarcinoma cell growth through suppression of Akt/mTOR signaling and induction of autophagy E Gurpinar, WE Grizzle, JJ Shacka, BJ Mader, N Li, NA Piazza, S Russo, ... Molecular cancer therapeutics 12 (5), 663-674, 2013 | 50 | 2013 |
| Preclinical pharmacology of BA-TPQ, a novel synthetic iminoquinone anticancer agent SJ Ezell, H Li, H Xu, X Zhang, E Gurpinar, X Zhang, ER Rayburn, ... Marine Drugs 8 (7), 2129-2141, 2010 | 29 | 2010 |
| Trisubstituted and tetrasubstituted pyrazolines as a novel class of cell-growth inhibitors in tumor cells with wild type p53 M Abdel-Halim, AB Keeton, E Gurpinar, BD Gary, SM Vogel, M Engel, ... Bioorganic & medicinal chemistry 21 (23), 7343-7356, 2013 | 9 | 2013 |
| Development and validation of an HPLC method for quantitation of BA‐TPQ, a novel iminoquinone anticancer agent, and an initial pharmacokinetic study in mice H Li, SJ Ezell, X Zhang, W Wang, H Xu, ER Rayburn, X Zhang, E Gurpinar, ... Biomedical Chromatography 25 (5), 628-634, 2011 | 9 | 2011 |
| A novel non-COX-inhibitory sulindac derivative induces autophagic cell death by inhibiting Akt signaling in lung cancer cells. E Gurpinar, WE Grizzle, JJ Shacka, N Li, AB Keeton, GA Piazza Cancer Research 73 (8_Supplement), 587-587, 2013 | | 2013 |
| Abstract LB-355: A novel non-COX-inhibitory sulindac derivative induces autophagic cell death in lung adenocarcinoma cells E Gurpinar, WE Grizzle, Y Liu, JJ Shacka, AB Keeton, GA Piazza Cancer Research 72 (8_Supplement), LB-355-LB-355, 2012 | | 2012 |
| NO-NSAIDs inhibit colon tumor cell growth by a cGMP-independent mechanism E Gurpinar, Y Sun, A Keeton, H Tinsley, B Gary, BL Butler, BF Binkowski, ... Cancer Research 71 (8_Supplement), 4610-4610, 2011 | | 2011 |
